American scientists have successfully tested a new tool that complements therapy for the treatment of the dangerous skin tumors – melanoma.
A study by the international group of scientists published in the scientific journal PNAS.
They tested the drug on laboratory mice with aggressive melanoma. Rodents received antibodies to PD-L1, which are already used in the treatment of tumors, as well as a new drug “Dprobit” that affects the immune system.
Similar to how a vaccine can train the body to fight against external pathogens, our medicine can train the immune system to fight against tumors
– said one of the study’s authors Dale Bogere.
During the 54 days of the experiment, scientists were able to achieve one hundred percent survival rate among experimental mice. If the drug will be safe for humans, in the future it can be used in therapy in the treatment of melanoma.
More news about treatment of different diseases, medicine in Ukraine, healthy lifestyle and nutrition, pregnancy and childbirth, discoveries in the field of medicine and more – see Health.